In Silico Approaches: A Way to Unveil Novel Therapeutic Drugs for Cervical Cancer Management
Cervical cancer (CC) is the fourth most common pathology in women worldwide and presents a high impact in developing countries due to limited financial resources as well as difficulties in monitoring and access to health services. Human papillomavirus (HPV) is the leading cause of CC, and despite th...
Main Authors: | Diana Gomes, Samuel Silvestre, Ana Paula Duarte, Aldo Venuti, Christiane P. Soares, Luís Passarinha, Ângela Sousa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/8/741 |
Similar Items
-
Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches
by: Pedro Cruz-Vicente, et al.
Published: (2021-04-01) -
In-silico Analysis of Human Papillomavirus – 45 E6, E7 & L1 Proteins as Potential Immunogens
by: Shruthi Padavu, et al.
Published: (2023-03-01) -
Interconnectedness threat: unveiling the mechanisms behind human papillomavirus-induced cervical cancer
by: Racheal Ahuoyiza Ayeni, et al.
Published: (2025-03-01) -
Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions
by: Jiatian Ye, et al.
Published: (2023-10-01) -
Diagnostic markers of human papillomavirus persistence and progression of cervical intraepithelial neoplasia
by: O. V. Khoperskaya, et al.
Published: (2022-01-01)